April 12, 2010

Draeger Medical Systems, Inc., US headquarters of Dräger Medical AG & Co. KG, an international leader in the fields of medical and safety technology and a worldwide leader in mechanical ventilation announced today that it has received 510(k) clearance from the FDA to market the Babylog VN500 in the US. The ventilator is Dräger’s most advanced product for neonatal ventilation.

New Babylog VN500 for Neonatal Ventilation

The Babylog VN500 ventilator offers the latest technology in mechanical ventilation specifically designed for the special needs of neonates and infants. Its versatility and range of operation is well suited for special care nurseries and pediatric intensive care units.

The Babylog VN500 combines important types of ventilation, such as conventional ventilation, nasal CPAP, and oxygen therapy in one medical device. The detachable control panel with 17" touch screen and rotary knob offers extended possibilities of device control and lung function monitoring.

“Designed with the clinician in mind, the Babylog VN500 combines the latest in technology coupled with a simplified and easy to use user interface,” said Ed Coombs, MA RRT and Associate Director of Marketing for Respiratory Care Systems at Draeger Medical, Inc. “After over two decades of experience with the Babylog 8000+, our customers have led the development of the next generation in neonatal ventilation.”

With a company-wide focus to provide exceptional product support services, Dräger customers will continue to receive support from both our field support teams and Intensive Care Online Network (ICON).

For more information, please contact your local Dräger sales representative at 1-800-437-2437.

Dräger Medical AG & Co. KG is the manufacturer of the Babylog VN500. Babylog® is a brand name of Dräger.

Dräger. Technology for Life®
The Drägerwerk AG & Co. KGaA is an international leader in the fields of medical and safety technology. Dräger products protect, support and save lives. Founded in 1889, in 2009 Dräger generated revenues of around EUR 1.9 billion. The Dräger Group is currently present in more than 190 countries and has about 11,000 employees worldwide.